First Cancer Diagnostic experiment Based on Rosetta Genomics’ Proprietary MicroRNA Technology Receives Regulatory Approval (PR Newswire via Yahoo! Finance)

Rosetta Genomics, Ltd. announces today that the first molecular pop quiz based on Rosetta Genomics’ proprietary microRNA technology, developed and validated by Columbia University Medical

Center , has been approved for clinical use by the New York State office of Health Clinical Laboratory Evaluation Program.

Original post by Ubergizmo

Comments are closed.